InterWell Health, LLC

InterWell Health, LLC specializes in value-based kidney care solutions, focusing on improving health outcomes for patients with kidney disease while effectively managing costs for healthcare payers. Founded in 2019 and headquartered in Waltham, US, InterWell Health provides comprehensive kidney care services. The company participated in a merger with Cricket Health, Inc. and Fresenius Health Partner Business in March 2022, which has expanded its service offerings.

The CEO, Robert Sepucha, has a background in healthcare management and has led various initiatives geared toward enhancing patient care. InterWell Health has completed two significant funding deals, with the latest being a Series B round that raised USD 46. 00 mn, bringing the total amount raised to USD 46. 00 mn.

InterWell Health primarily offers value-based kidney care solutions aimed at enhancing health outcomes for kidney disease patients while reducing costs for payers. Their services include comprehensive patient management facilitated by a multidisciplinary team comprising nephrologists, nurses, dietitians, and social workers. The innovative care model focuses on early intervention and predictive analytics to proactively identify at-risk patients. Their solutions cater to various stakeholders in the healthcare system, including payers and healthcare providers, ensuring accessibility across all 50 states in the U.

S. InterWell Health generates revenue through partnerships with healthcare providers, payers, and nephrology practices. The business model is structured around value-based care principles, aligning incentives with performance outcomes, typically on a per member per month (PMPM) basis. This model reflects cost savings from reduced hospitalizations and improved health metrics, enabling payers to lower overall healthcare expenditures.

Following the recent funding round in March 2022, which included investments from Valtruis, Blue Shield of California, and others, InterWell Health aims to leverage these resources for future growth. The company is exploring adjacent value-based care opportunities to enhance its service offerings and is strategically planning to expand its market presence. Specific geographic regions targeted for expansion will further enhance patient access to their advanced care protocols, with a focus on developing market strategies over the next few years.